Opportunities center on NPPT-coated and blended urea, nitrogen stabilizers, controlled-release products, and climate-smart formulations with emissions verification. Asia-Pacific offers strong ...
According to MarketsandMarkets™, the controlled-release fertilizers market is projected to reach USD 3.61 billion by 2031 from USD 2.69 ...
Trials of current B cell-directed therapies and an investigational inhibitor of the alternative complement pathway demonstrate proteinuria reduction in patients with IgA nephropathy. Targeting ...
Trutakna (atacicept-vymj), a first-in-class dual BAFF and APRIL inhibitor, secured FDA accelerated approval to reduce proteinuria in adults with primary IgA nephropathy, supported by data ...
Hosted on MSN
Oral Drug Wins FDA Approval for Chronic Hives
The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic hives, Novartis announced on Tuesday. Indicated for adults with stubborn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results